Kazia Presents Interim Paxalisib Phase II Data at ASCO Showing Positive Overall Survival Signal
So Kazia interim GDC 0084 data was "released" at the most prestigious cancer conference in the US today...and the market reaction was Blah Blah.
Serious question for Hot Copper board...Why is the Kazia market cap at only 21 million USD?
Am I missing something?
Serious replies please